Cell-based immunotherapy called CAR-T cell therapy has revolutionized the treatment of several cancers. The treatment uses genetically modified T cells to target and attack certain types of leukemia and lymphoma. While it ...
Sep 1, 2022
0
44
Women with a breast cancer diagnosis undergoing procedures for fertility preservation are not at increased risk of recurrence of the disease or disease-specific mortality. This has been shown in a study by Karolinska Institutet ...
Aug 25, 2022
0
16
The repercussions of overturning Roe v. Wade—and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother—are potentially catastrophic for a subset of women who ...
Aug 15, 2022
0
61
Prostate-specific antigen (PSA) screening is associated with decreased risk of prostate cancer-specific mortality (PCSM) among both Black and White men, according to a study published online Aug. 4 in JAMA Oncology.
Aug 10, 2022
0
2
Smokers for whom annual screening with low-dose computed tomography (LDCT) is not recommended may have a high risk for lung cancer, according to a study published online July 28 in JAMA Oncology.
Aug 9, 2022
0
2
A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill clinical trials and enroll sufficiently diverse groups of patients for results to reflect the broader population, in ...
Aug 5, 2022
0
20
Dr. Yuanjie Mao has led a study published in JAMA Oncology looking at the correlation between daily insulin dose and cancer incidence (the number of new cases) among patients with type 1 diabetes, finding that higher insulin ...
Jul 29, 2022
0
1141
Despite a commitment from the pharmaceutical industry in 2014 to improve data transparency, more than half of the clinical trials that led to the United States Food and Drug Administration approving anticancer medicines over ...
Jul 28, 2022
0
3
The age-adjusted incidence rate of anaplastic large-cell lymphoma (ALCL) of the breast is increasing rapidly in the United States, according to a research letter published online July 21 in JAMA Oncology.
Jul 26, 2022
0
2
In a study of patients with borderline resectable pancreatic cancer, combination chemotherapy with modified FOLFIRINOX before surgery increased survival relative to historical data and compared favorably to FOLFIRINOX plus ...
Jul 14, 2022
0
21
